Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 7/2008

01.10.2008 | ORIGINAL PAPER

Insight, cognitive dysfunction and symptomatology in schizophrenia

verfasst von: Luciana C. Monteiro, Vanessa A. Silva, Mario R. Louzã

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Lack of insight is frequent in schizophrenia and usually influences negatively both patient’s treatment and prognosis. This study aimed to investigate the relationship between insight, symptomatology and cognitive dysfunctions in schizophrenia using the PANSS five-factor model (modified from Gaag et al. in Schizophr Res 85:280–287, 2006). Forty patients diagnosed with chronic schizophrenia (DSM-IV) were evaluated with the scale to assess unawareness of mental disorder (SUMD), the PANSS and a neuropsychological battery. Spearman correlation and linear regression analyses were performed to investigate the relationship between clinical, neurocognitive and insight measures. The SUMD current and past awareness of symptoms score showed a correlation with WCST indices (correct answers and non-persevering errors). The negative and disorganization factor of the PANSS showed a positive correlation with current and past awareness of symptoms. However, when submitted to a linear regression model only the disorganization factor emerged as significant contributor for insight. Considering that the core items of the “disorganization factor” of the PANSS are related to cognition (e.g., poor attention, difficult in abstract thinking), insight is associated cognitive symptoms although no direct relationship between insight and neuropsychological tests was observed.
Literatur
1.
Zurück zum Zitat Aleman A, Agrawal N, Morgan KD, David AS (2006) Insight in psychosis and neuropsychological function. Br J Psychiatry 189:204–212PubMedCrossRef Aleman A, Agrawal N, Morgan KD, David AS (2006) Insight in psychosis and neuropsychological function. Br J Psychiatry 189:204–212PubMedCrossRef
2.
Zurück zum Zitat Amador XF, David HS, Yale SA, Gorman JM (1991) Awareness of illness in schizophrenia. Schizophr Bull 17:113–131PubMed Amador XF, David HS, Yale SA, Gorman JM (1991) Awareness of illness in schizophrenia. Schizophr Bull 17:113–131PubMed
3.
Zurück zum Zitat Amador XF, Gorman JM (1998) Psychopathologic domains and insight in schizophrenia. Psych Clin North Am 21:27–41CrossRef Amador XF, Gorman JM (1998) Psychopathologic domains and insight in schizophrenia. Psych Clin North Am 21:27–41CrossRef
4.
Zurück zum Zitat American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). APA, Washington, DC American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). APA, Washington, DC
5.
Zurück zum Zitat Benton AL, Hamsher KD, Varney NR, Spreen O (1994) Contributions to neuropsychology assessment: a clinical manual. Oxford University Press, New York Benton AL, Hamsher KD, Varney NR, Spreen O (1994) Contributions to neuropsychology assessment: a clinical manual. Oxford University Press, New York
6.
Zurück zum Zitat Chaves AC, Shirakawa I (2000) Escalas das síndromes negativa e positiva – e seu uso no Brasil. In: Gorenstein C, Andrade LHSG, Zuardi AW (eds) Escalas de avaliação clínica em psiquiatria e psicofarmacologia. Editora Lemos, São Paulo, pp 219–224 Chaves AC, Shirakawa I (2000) Escalas das síndromes negativa e positiva – e seu uso no Brasil. In: Gorenstein C, Andrade LHSG, Zuardi AW (eds) Escalas de avaliação clínica em psiquiatria e psicofarmacologia. Editora Lemos, São Paulo, pp 219–224
7.
Zurück zum Zitat Collins AA, Remington GJ, Coulter K, Birkett K (1997) Insight, neurocognitive function and symptom clusters in chronic schizophrenia. Schizophr Res 27:37–44PubMedCrossRef Collins AA, Remington GJ, Coulter K, Birkett K (1997) Insight, neurocognitive function and symptom clusters in chronic schizophrenia. Schizophr Res 27:37–44PubMedCrossRef
8.
Zurück zum Zitat Conners K (2002) CPT-II—continuous performance test II. Multi-Health Systems Inc, Conners K (2002) CPT-II—continuous performance test II. Multi-Health Systems Inc,
9.
Zurück zum Zitat Cuesta MJ, Peralta V (1994) Lack of insight in schizophrenia. Schizophr Bull 20:359–366PubMed Cuesta MJ, Peralta V (1994) Lack of insight in schizophrenia. Schizophr Bull 20:359–366PubMed
10.
Zurück zum Zitat Cuesta MJ, Peralta V, Zarzuela A, Zandio M (2006) Insight dimensions and cognitive function in psychosis: a longitudinal study. BMC Psychiatry 6:26PubMedCrossRef Cuesta MJ, Peralta V, Zarzuela A, Zandio M (2006) Insight dimensions and cognitive function in psychosis: a longitudinal study. BMC Psychiatry 6:26PubMedCrossRef
11.
Zurück zum Zitat Donohoe G, Corvin A, Robertson IH (2005) Are the cognitive deficits associated with impaired insight in schizophrenia specific to executive task performance? J Nerv Ment Dis 193:803–808PubMedCrossRef Donohoe G, Corvin A, Robertson IH (2005) Are the cognitive deficits associated with impaired insight in schizophrenia specific to executive task performance? J Nerv Ment Dis 193:803–808PubMedCrossRef
12.
Zurück zum Zitat Drake RJ, Lewis SW (2003) Insight and neurocognition in schizophrenia. Schizophr Res 62:165–173PubMedCrossRef Drake RJ, Lewis SW (2003) Insight and neurocognition in schizophrenia. Schizophr Res 62:165–173PubMedCrossRef
13.
Zurück zum Zitat Fiss N, Chaves AC (2005) Translation, adaptation and reliability study of the scale to assess unawareness of mental disorder—SUMD. Rev Br Psiquiatria 27:143–145 Fiss N, Chaves AC (2005) Translation, adaptation and reliability study of the scale to assess unawareness of mental disorder—SUMD. Rev Br Psiquiatria 27:143–145
14.
Zurück zum Zitat Gaag M, Hoffman T, Remijsen M, Hijman R, Haan L, Meijel B, Harten PN, Valmaggia L, Hert M, Cuijpers A, Wiersma D (2006) The five-factor model of the positive and negative syndrome scale II: a ten-fold cross-validation of a revised model. Schizophr Res 85:280–287PubMedCrossRef Gaag M, Hoffman T, Remijsen M, Hijman R, Haan L, Meijel B, Harten PN, Valmaggia L, Hert M, Cuijpers A, Wiersma D (2006) The five-factor model of the positive and negative syndrome scale II: a ten-fold cross-validation of a revised model. Schizophr Res 85:280–287PubMedCrossRef
15.
Zurück zum Zitat Goodman C, Knoll G, Isakov V, Silver H (2005) Insight into illness in schizophrenia. Compr Psychiatry 46:284–290PubMedCrossRef Goodman C, Knoll G, Isakov V, Silver H (2005) Insight into illness in schizophrenia. Compr Psychiatry 46:284–290PubMedCrossRef
16.
Zurück zum Zitat Heaton RK (2003) WCST-64: computer version 2—research edition. Psycological Assessment Resources, Odessa Heaton RK (2003) WCST-64: computer version 2—research edition. Psycological Assessment Resources, Odessa
17.
Zurück zum Zitat Laroi F, Fannemel M, Ronneberg U, Flekkoy K, Opjordsmoen S, Dullerud R, Haakonsen M (2000) Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Res Neuroimage Sect 100:49–58CrossRef Laroi F, Fannemel M, Ronneberg U, Flekkoy K, Opjordsmoen S, Dullerud R, Haakonsen M (2000) Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Res Neuroimage Sect 100:49–58CrossRef
18.
Zurück zum Zitat Laws KR (1999) A meta-analytic review of Wisconsin card sort studies in schizophrenia: general intellectual deficit? Cogn Neuropsychiatry 4(1):1–35CrossRefPubMed Laws KR (1999) A meta-analytic review of Wisconsin card sort studies in schizophrenia: general intellectual deficit? Cogn Neuropsychiatry 4(1):1–35CrossRefPubMed
19.
Zurück zum Zitat Lysaker P, Bell M (1994) Insight and cognitive impairment in schizophrenia: performance on repeated administrations of the Wisconsin card sorting test. J Nerv Ment Dis 182:656–660PubMed Lysaker P, Bell M (1994) Insight and cognitive impairment in schizophrenia: performance on repeated administrations of the Wisconsin card sorting test. J Nerv Ment Dis 182:656–660PubMed
20.
Zurück zum Zitat Lysaker PH, Bell MD, Bryson G, Kaplan E (1998) Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function. Acta Psychiatr Scand 97:297–301PubMedCrossRef Lysaker PH, Bell MD, Bryson G, Kaplan E (1998) Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function. Acta Psychiatr Scand 97:297–301PubMedCrossRef
21.
Zurück zum Zitat Lysaker PH, Bryson GJ, Lancaster RS, Evans JD, Bell MD (2002) Insight in schizophrenia: associations with executive function and coping style. Schizophr Res 59:41–47CrossRef Lysaker PH, Bryson GJ, Lancaster RS, Evans JD, Bell MD (2002) Insight in schizophrenia: associations with executive function and coping style. Schizophr Res 59:41–47CrossRef
22.
Zurück zum Zitat Maccabe R, Quayle E, Beirne AD, Duane MMA (2002) Insight, global neuropsychological functioning, and symptomatology in chronic schizophrenia. J Nerv Ment Dis 190:519–525CrossRef Maccabe R, Quayle E, Beirne AD, Duane MMA (2002) Insight, global neuropsychological functioning, and symptomatology in chronic schizophrenia. J Nerv Ment Dis 190:519–525CrossRef
23.
Zurück zum Zitat McEvoy JP, Hartman M, Gottlieb D, Godwin S, Apperson LJ, Wilson W (1996) Common sense, insight, and neuropsychological test performance in schizophrenia patients. Schizophr Bull 22:635–641PubMed McEvoy JP, Hartman M, Gottlieb D, Godwin S, Apperson LJ, Wilson W (1996) Common sense, insight, and neuropsychological test performance in schizophrenia patients. Schizophr Bull 22:635–641PubMed
24.
Zurück zum Zitat Medalia A, Lim RW (2004) Self-awareness of cognitive unctioning in schizophrenia. Schizophr Res 71:331–338PubMedCrossRef Medalia A, Lim RW (2004) Self-awareness of cognitive unctioning in schizophrenia. Schizophr Res 71:331–338PubMedCrossRef
25.
Zurück zum Zitat Mintz AR, Dobson KS, Romney DM (2003) Insight in schizophrenia: a meta-analysis. Schizophr Res 61:75–88PubMedCrossRef Mintz AR, Dobson KS, Romney DM (2003) Insight in schizophrenia: a meta-analysis. Schizophr Res 61:75–88PubMedCrossRef
26.
Zurück zum Zitat Mohamed S, Fleming S, Penn DL, Spaulding W (1999) Insight in schizophrenia: its relationship to measures of executive functions. J Nerv Ment Dis 187:525–531PubMedCrossRef Mohamed S, Fleming S, Penn DL, Spaulding W (1999) Insight in schizophrenia: its relationship to measures of executive functions. J Nerv Ment Dis 187:525–531PubMedCrossRef
27.
Zurück zum Zitat Reitan RM (1958) Validity of the trail making test as a indicator of organic brain damage. Percept Motor Skills 8:271–276 Reitan RM (1958) Validity of the trail making test as a indicator of organic brain damage. Percept Motor Skills 8:271–276
28.
Zurück zum Zitat Rey A. Teste de cópia e de reprodução de memória de figuras geométricas complexas. Adaptação Brasileira. Tradução: Oliveira MS (1998; 1999) Casa do Psicólogo, São Paulo Rey A. Teste de cópia e de reprodução de memória de figuras geométricas complexas. Adaptação Brasileira. Tradução: Oliveira MS (1998; 1999) Casa do Psicólogo, São Paulo
29.
Zurück zum Zitat Rossell SL, Coakes J, Shapleske J, Woodruff PWR, David AS (2003) Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med 33:111–119PubMedCrossRef Rossell SL, Coakes J, Shapleske J, Woodruff PWR, David AS (2003) Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med 33:111–119PubMedCrossRef
30.
Zurück zum Zitat Sevy S, Nathanson K, Visweswaraiah H, Amador X (2004) The relationship between insight and symptoms in schizophrenia. Comp Psychiatry 45:16–19CrossRef Sevy S, Nathanson K, Visweswaraiah H, Amador X (2004) The relationship between insight and symptoms in schizophrenia. Comp Psychiatry 45:16–19CrossRef
31.
Zurück zum Zitat Smith TE, Hull JW, Goodman M, Hedayat-Harris A, Wisson DF, Israel LM, Munich RL (1999) The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 187:102–108PubMedCrossRef Smith TE, Hull JW, Goodman M, Hedayat-Harris A, Wisson DF, Israel LM, Munich RL (1999) The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 187:102–108PubMedCrossRef
32.
Zurück zum Zitat Smith TE, Hull JW, Israel LM, Willson DF (2000) Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder. Schizophr Bull 26:193–200PubMed Smith TE, Hull JW, Israel LM, Willson DF (2000) Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder. Schizophr Bull 26:193–200PubMed
33.
Zurück zum Zitat Spreen O, Etrauss E (1998) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, New York Spreen O, Etrauss E (1998) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, New York
34.
Zurück zum Zitat Startup M (1996) Insight and cognitive deficits in schizophrenia: evidence for a curvilinear relationship. Psychol Med 26:1277–1281PubMedCrossRef Startup M (1996) Insight and cognitive deficits in schizophrenia: evidence for a curvilinear relationship. Psychol Med 26:1277–1281PubMedCrossRef
35.
Zurück zum Zitat Subotnik KL, Nuechterlein KH, Irzhevsky V, Kitchen CM, Woo SM, Mintz J (2005) Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem? Schizophr Res 75:147–157PubMedCrossRef Subotnik KL, Nuechterlein KH, Irzhevsky V, Kitchen CM, Woo SM, Mintz J (2005) Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem? Schizophr Res 75:147–157PubMedCrossRef
36.
Zurück zum Zitat Wechsler D (1981) Wechsler intelligence scale—revised. Psychological Corporation, New York Wechsler D (1981) Wechsler intelligence scale—revised. Psychological Corporation, New York
37.
Zurück zum Zitat Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667PubMedCrossRef Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667PubMedCrossRef
38.
Zurück zum Zitat Young DA, Zakzanis KK, Bailey C, Davila R, Griese J, Sartory G, Thom A (1998) Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease. J Nerv Ment Dis 186:44–50PubMedCrossRef Young DA, Zakzanis KK, Bailey C, Davila R, Griese J, Sartory G, Thom A (1998) Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease. J Nerv Ment Dis 186:44–50PubMedCrossRef
Metadaten
Titel
Insight, cognitive dysfunction and symptomatology in schizophrenia
verfasst von
Luciana C. Monteiro
Vanessa A. Silva
Mario R. Louzã
Publikationsdatum
01.10.2008
Verlag
D. Steinkopff-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 7/2008
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-008-0809-8

Weitere Artikel der Ausgabe 7/2008

European Archives of Psychiatry and Clinical Neuroscience 7/2008 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.